These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2494195)

  • 1. Dynamic interactions of c-fos protein in serum-stimulated 3T3 cells.
    Vosatka RJ; Hermanowski-Vosatka A; Metz R; Ziff EB
    J Cell Physiol; 1989 Mar; 138(3):493-502. PubMed ID: 2494195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of modification in c-fos and its associated protein p39: modulation of DNA binding by phosphorylation.
    Müller R; Bravo R; Müller D; Kurz C; Renz M
    Oncogene Res; 1987; 2(1):19-32. PubMed ID: 3146046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity.
    Gruda MC; Kovary K; Metz R; Bravo R
    Oncogene; 1994 Sep; 9(9):2537-47. PubMed ID: 8058317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts.
    Lallemand D; Spyrou G; Yaniv M; Pfarr CM
    Oncogene; 1997 Feb; 14(7):819-30. PubMed ID: 9047389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
    Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
    Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kainic acid-induced excitotoxicity is associated with a complex c-Fos and c-Jun response which does not preclude either cell death or survival.
    Pozas E; Ballabriga J; Planas AM; Ferrer I
    J Neurobiol; 1997 Sep; 33(3):232-46. PubMed ID: 9298762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence and possible role of c-ras and nuclear (c-fos and c-jun) proto-oncogene products in preimplantation embryonic development in mice.
    Ahmad K; Naz RK
    Mol Reprod Dev; 1993 Nov; 36(3):297-306. PubMed ID: 8286110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Fos protein complexes and Fos-related antigens by high-resolution two-dimensional gel electrophoresis.
    Franza BR; Sambucetti LC; Cohen DR; Curran T
    Oncogene; 1987 May; 1(2):213-21. PubMed ID: 3325882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells.
    Shibanuma M; Kuroki T; Nose K
    Oncogene; 1990 Jul; 5(7):1025-32. PubMed ID: 2115640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain.
    Sonnenberg JL; Mitchelmore C; Macgregor-Leon PF; Hempstead J; Morgan JI; Curran T
    J Neurosci Res; 1989 Sep; 24(1):72-80. PubMed ID: 2553994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.
    Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor cell proteins, detected using antibodies to the S- and N-terminal fragments of the fos proto-oncogene product].
    Mazurenko NN; Kiseleva NP; Kudriavets IuI; Mikhaleva II; Antonenko VV; Kiselev FL
    Mol Biol (Mosk); 1990; 24(5):1351-62. PubMed ID: 2127073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
    Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
    BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
    Rozengurt E; Sinnett-Smith JW
    J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse.
    Pandey S; Wang E
    J Cell Biochem; 1995 Jun; 58(2):135-50. PubMed ID: 7673322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of serum response factor by casein kinase II: evidence against a role in growth factor regulation of fos expression.
    Manak JR; Prywes R
    Oncogene; 1993 Mar; 8(3):703-11. PubMed ID: 8437853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
    Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
    Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.